Yusuke Kurita, Kensuke Kubota, Yuji Fujita, Seitaro Tsujino, Yusuke Sekino, Noriki Kasuga, Akito Iwasaki, Mai Iwase, Takeshi Izuka, Koichi Kagawa, Emiko Tanida, Shin Yagi, Sho Hasegawa, Takamitsu Sato, Kunihiro Hosono, Noritoshi Kobayashi, Yasushi Ichikawa, Atsushi Nakajima, Itaru Endo
BACKGROUND: The risk and prognosis of pancreatobiliary cancer and in patients with autoimmune pancreatitis (AIP) and IgG4-related sclerosing cholangitis (IgG4-SC) remain unclear. Therefore, we retrospectively investigated the risk of pancreatobiliary cancer and prognosis in patients with AIP and IgG4-SC. METHODS: Patients with AIP and IgG4-SC at seven centers between 1998 and 2022 were investigated. The following data were evaluated: (1) the number of cancers diagnosed and standardized incidence ratio (SIR) for pancreatobiliary and other cancers during the observational period and (2) prognosis after diagnosis of AIP and IgG4-SC using standardized mortality ratio (SMR)...
December 20, 2023: Journal of Hepato-biliary-pancreatic Sciences